Eli Lilly is gearing up to announce its fiscal 2025 fourth-quarter earnings in the near term, and analysts project its ...

Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump administration ...

Drugmakers plan to raise U.S. prices on at least 350 branded medications in 2026, including vaccines for COVID-19 and shingles, migraine treatments, and blockbuster cancer drugs, according to data ...

NEW YORK – Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID-19, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump ...

NEW YORK, Dec 31 (Reuters) - Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even ...

Expanded use of GLP-1 drugs may lead to more side effects, already the subject of thousands of lawsuits now moving through the courts. Thousands of patients have filed lawsuits claiming the makers of ...

GLP-1 medications have rapidly become some of the most influential treatments for Type 2 diabetes and weight loss. As more people look into these prescriptions, there is growing curiosity about how ...

Medicare enrollees could save roughly half of what they usually pay for certain drugs next year, according to a study from the AARP. The study, published Thursday, found that the out-of-pocket cost of ...

Here's how the next generation of obesity drugs getting closer to patients differs from Wegovy and Zepbound Novo Nordisk (whose injectable weight-loss medication Wegovy is shown here) and rival Eli ...